6F
BMY icon

626 Financial’s Bristol-Myers Squibb BMY Stock Holding History

626 Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713K Sell
12,372
-1,889
-13% -$108K 0.28% 55
2026
Q1 		$865K Buy
14,261
+4,393
+45% +$256K 0.39% 44
2025
Q4 		$532K Sell
9,868
-214
-2% -$10.3K 0.23% 60
2025
Q3 		$455K Buy
10,082
+10
+0.1% +$467 0.2% 70
2025
Q2 		$466K Sell
10,072
-154
-2% -$7.56K 0.22% 67
2025
Q1 		$624K Buy
10,226
+173
+2% +$10.1K 0.32% 51
2024
Q4 		$569K Buy
10,053
+699
+7% +$39.1K 0.31% 55
2024
Q3 		$484K Sell
9,354
-60
-0.6% -$2.81K 0.27% 62
2024
Q2 		$391K Sell
9,414
-375
-4% -$16.8K 0.23% 72
2024
Q1 		$531K Sell
9,789
-876
-8% -$44.6K 0.32% 56
2023
Q4 		$547K Sell
10,665
-40
-0.4% -$2.1K 0.36% 50
2023
Q3 		$621K Sell
10,705
-249
-2% -$15.3K 0.42% 50
2023
Q2 		$701K Sell
10,954
-218
-2% -$14.6K 0.45% 42
2023
Q1 		$774K Sell
11,172
-87
-0.8% -$6.14K 0.51% 44
2022
Q4 		$810K Buy
11,259
+11
+0.1% +$829 0.56% 41
2022
Q3 		$800K Buy
11,248
+11
+0.1% +$798 0.65% 37
2022
Q2 		$864K Buy
11,237
+11
+0.1% +$838 0.65% 32
2022
Q1 		$820K Sell
11,226
-141
-1% -$9.47K 0.53% 42
2021
Q4 		$709K Buy
+11,367
New +$667K 0.43% 44
2021
Q1 		$820K Buy
+11,226
New +$698K 0.53% 42

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

626 Financial's BMY Position: Q2 2026 in Review

626 Financial reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $108K and leaving 12,372 shares worth $713K. The position accounts for 0.28% of the portfolio, ranked #55.

626 Financial first reported a position in BMY in Q1 2021 and has held it in 20 quarters since. The position peaked at $865K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • 626 Financial held 12,372 shares of Bristol-Myers Squibb worth $713K as of Q2 2026.
  • 626 Financial sold 1,889 Bristol-Myers Squibb shares in Q2 2026, an estimated $108K.
  • Bristol-Myers Squibb made up 0.28% of 626 Financial's portfolio in Q2 2026, its #55 holding.
  • 626 Financial first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 20 quarters since.
  • 626 Financial's Bristol-Myers Squibb position peaked at $865K in Q1 2026.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on 626 Financial's 13F filing for Q2 2026, filed 27 Jul 2026.